Neoplasms and Cardiovascular Diseases

At Erasmus Universitair Medisch Centrum Rotterdam, clinical research spans both cancer and heart disease, with studies focused on improving treatment outcomes and supporting better disease control. The work includes trials in medical oncology as well as cardiology, reflecting a broad interest in advancing care for serious conditions.

• Research in muscle invasive bladder cancer is evaluating whether adding a new therapy to standard chemoradiotherapy can improve disease control and event-free survival.
• Studies in diffuse large B-cell lymphoma are exploring treatment strategies for aggressive blood cancers, with the goal of strengthening response and reducing the risk of relapse.
• A heart failure trial is assessing the safety and tolerability of a new cardiovascular treatment approach for patients living with chronic cardiac disease.

Across these trials, the main emphasis is on testing new therapies and improving how well current treatments work for patients with difficult-to-treat malignancies and cardiovascular conditions.